HRPMF
Price:
$3.51
Market Cap:
$51.08M
Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying CDNF-based therapies for Parkinson's disease (PD). Its lead product in pipeline includes HER-096, an advanced small and synthetic chemical peptidomimetic version of the active parent as the preclinical xCDNF candidate for the treatment of PD and other neurodegenerative diseases; and recombinant human Cerebral Dopamine Neurotrophic Factor (rhCDNF), a biological protein that is in Phase I study in patients with PD. The company was incorporated in 2008 and is based in Espoo, Finland.
Industry
Biotechnology
IPO Date
2018-10-30
Stock Exchange
OTC
Ticker
HRPMF
According to Herantis Pharma Oyj’s latest financial reports and current stock price. The company's current PE Ratio is -2.22. This represents a change of 295.48% compared to the average of -0.56 of the last 4 quarters.
The mean historical PE Ratio of Herantis Pharma Oyj over the last ten years is 5.83. The current -2.22 PE Ratio has changed -3913.24% with respect to the historical average. Over the past ten years (40 quarters), HRPMF's PE Ratio was at its highest in in the December 2023 quarter at 6.66. The PE Ratio was at its lowest in in the December 2017 quarter at -45.62.
Average
5.83
Median
-3.07
Minimum
-10.72
Maximum
97.08
Discovering the peaks and valleys of Herantis Pharma Oyj PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 850.36%
Maximum Annual PE Ratio = 97.08
Minimum Annual Increase = -3843.79%
Minimum Annual PE Ratio = -10.72
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -6.20 | -106.39% |
| 2023 | 97.08 | -3843.79% |
| 2022 | -2.59 | 149.62% |
| 2021 | -1.04 | -69.01% |
| 2020 | -3.35 | -43.65% |
| 2019 | -5.95 | 1.13% |
| 2018 | -5.88 | -45.14% |
| 2017 | -10.72 | 284.53% |
| 2016 | -2.79 | 850.36% |
| 2015 | -0.29 | -87.04% |
The current PE Ratio of Herantis Pharma Oyj (HRPMF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
29.43
5-year avg
16.78
10-year avg
5.83
Herantis Pharma Oyj’s PE Ratio is greater than Oncopeptides AB (publ) (-4.54), greater than Biostage, Inc. (-9.60), greater than Mindset Pharma Inc. (-4.01), greater than Goodness Growth Holdings, Inc. (-6.01), greater than Abliva AB (publ) (-9.56), less than Karolinska Development AB (publ) (-0.68), less than Elegance Optical International Holdings Limited (0), less than Relief Therapeutics Holding AG (-2.06), less than Small Pharma Inc. (-2.18), less than SymBio Pharmaceuticals Limited (-1.01),
| Company | PE Ratio | Market cap |
|---|---|---|
| -4.54 | $55.98M | |
| -9.60 | $57.82M | |
| -4.01 | $54.51M | |
| -6.01 | $61.05M | |
| -9.56 | $45.13M | |
| -0.68 | $68.85M | |
| 0 | $63.38M | |
| -2.06 | $44.94M | |
| -2.18 | $37.51M | |
| -1.01 | $30.49M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Herantis Pharma Oyj using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Herantis Pharma Oyj or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Herantis Pharma Oyj's PE Ratio?
How is the PE Ratio calculated for Herantis Pharma Oyj (HRPMF)?
What is the highest PE Ratio for Herantis Pharma Oyj (HRPMF)?
What is the 3-year average PE Ratio for Herantis Pharma Oyj (HRPMF)?
What is the 5-year average PE Ratio for Herantis Pharma Oyj (HRPMF)?
How does the current PE Ratio for Herantis Pharma Oyj (HRPMF) compare to its historical average?